Home › Kanser sa Atay (Hepatocellular Carcinoma) › Michigan › Detroit
Pag-aaral pangklinika para sa Kanser sa Atay (Hepatocellular Carcinoma) sa Detroit, MI
Isang pag-aaral para sa Kanser sa Atay (Hepatocellular Carcinoma) ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Detroit. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
The Vanguard Study: Testing a New Way to Screen for Cancer
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
- Henry Ford Hospital, Detroit
- Henry Ford Medical Center - Detroit Northwest, Detroit
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Nagre-recruitPhase 1
- Exelixis Clinical Site #65, Detroit
- Exelixis Clinical Site #13, Detroit
National Liver Cancer Screening Trial
Nagre-recruitPhase 4
- Henry Ford Health System, Detroit
A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants With First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC) (ROSETTA HCC-206)
Nagre-recruitPhase 1/2
- Local Institution - 0134, Detroit
Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations
Nagre-recruitPhase 1
- Karmanos Cancer Institute, Detroit
Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)
Nagre-recruitObservasyonal na pag-aaral
- Henry Ford Health, Detroit
Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma
Nagre-recruitPhase 3
- Research Site, Detroit
Testing Immunotherapy With or Without Stereotactic Body Radiation Therapy in Patients With Advanced Liver Cancer, HELIO-RT Trial
Nagre-recruitPhase 3
- Henry Ford Hospital, Detroit
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
Nagre-recruitPhase 1
- Karmanos Cancer Institute, Detroit
A Study of TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular Carcinoma
Nagre-recruitPhase 1/2
- Barbara Ann Karmanos Cancer Institute, Detroit
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
Nagre-recruitPhase 1/2
- Research Site 129, Detroit
Pag-aaral para sa Kanser sa Atay (Hepatocellular Carcinoma) sa ibang lungsod
- Houston, TX31 pag-aaral
- New York City, NY24 pag-aaral
- Dallas, TX19 pag-aaral
- Los Angeles, CA19 pag-aaral
- Boston, MA18 pag-aaral
- Cleveland, OH18 pag-aaral
- Philadelphia, PA16 pag-aaral
- Chicago, IL16 pag-aaral
- Pittsburgh, PA15 pag-aaral
- San Francisco, CA14 pag-aaral
- Orange, CA14 pag-aaral
- Jacksonville, FL14 pag-aaral
Iba pang pag-aaral sa Detroit
- Non-Small Cell Lung Cancer44 pag-aaral
- Kanser sa Suso33 pag-aaral
- Kanser (lahat ng uri)29 pag-aaral
- Colorectal Cancer26 pag-aaral
- Kanser sa Ovary26 pag-aaral
- Metastatic Cancer24 pag-aaral
- Kanser sa Prostate22 pag-aaral
- Kanser ng Endometrium21 pag-aaral
- Kanser sa Baga20 pag-aaral
- Multiple Myeloma19 pag-aaral
- Kanser sa Tiyan16 pag-aaral
- Squamous Cell Carcinoma ng Ulo at Leeg15 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.